Corrigendum to ‘Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial’ [eBioMedicine 127 (2026) 106268] doi: 10.1016/j.ebiom.2026.106268

2026-08-01

Liem T. Nguyen *

Kien T. Nguyen

Lan T.M. Dao

Van T. Hoang

Trang T. K. Phan

Nhung T.H. Dinh

Ha T. Nguyen

Anh T.P. Nguyen

Thuy T.N. Nguyen

Thanh T.K. Ho

Quyet M. Nguyen

DOI：10.1016/j.ebiom.2026.106422

Original request for help

Save

Abstract